Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) falls more steeply than broader market: What investors need to know
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $54.74, moving -2.2% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 1.16%.
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, Tax Shelters, Insurance bonds. Are quality global small-caps poised for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results